Grant Opportunities NINDS SBIR Technology Transfer (SBIR-TT [R43/R44])- Sep 14, 2014 ... Funding Opportunity Number: PA-11-347 Opportunity Category: Discretionary Funding Instrument Type: Grant Category of Funding Activity: Health CFDA Number: 93.23393.83793.83893.83993.85393.867…Super UserOctober 1, 2013
BHI Weekly News Archives 64th Edition – October 1, 2013 You're receiving this newsletter because of your interest in BioHealth Innovation Having trouble viewing this email? View it in your…Super UserOctober 1, 2013
News Is your school underrated for tech entrepreneurship? – PandoDaily At a time when many states are looking to their research universities as sources of innovation and entrepreneurship, it is…Super UserSeptember 30, 2013
News Emergent to Buy Gaithersburg Office from COPT – Daily News Article – GlobeSt.com Emergent Biosolutions, the maker of the only FDA-licensed anthrax vaccine, is expanding its footprint in Montgomery County, with a little…Super UserSeptember 30, 2013
News Here’s a look at healthcare’s top 10 corporate investors and acquirers – MedCity News These days, having a strategic investor or partner has become almost a matter of survival for healthcare startups. Corporate investing…Super UserSeptember 30, 2013
News University of Maryland entrepreneurship program extends eligibility to all majors – The Diamondback : Campus Anyone can have a great business idea, and now students don’t have to be enrolled in the business school to…Super UserSeptember 30, 2013
News Getting Big Results from a Small Business Unit – Steven J. Thompson – Harvard Business Review Earlier this year Sun Yat-sen University, a well-regarded institution in Guangzhou in the Guangdong province of China, announced that the…Super UserSeptember 30, 2013
News The Pharma Bureaucracy Index: Who’s Nimble, and Who’s Sloooowww? – Xconomy Bureaucracy is one of the dirty words in business. Nobody wants to publicly admit their company is bogged down with…Super UserSeptember 30, 2013
News Gliknik Enters Into Licensing Agreement With Pfizer for Drug Candidate Targeting Autoimmune Diseases GL-2045 is Gliknik’s Lead Recombinant Stradomer™ Designed to Improve on Pooled Human Intravenous Immunoglobulin Gliknik Inc., a privately held biopharmaceutical…Super UserSeptember 30, 2013
News The Pharma Bureaucracy Index: Who’s Nimble, and Who’s Sloooowww? Bureaucracy is one of the dirty words in business. Nobody wants to publicly admit their company is bogged down with…Super UserSeptember 30, 2013